Total抗体とリン酸化抗体のCSTジャパン株式会社

Cell Cycle / Checkpoint Control

CSTコード 包装
希望納入価格(円)
国内在庫 i
2010年9月9日14時20分 現在
ご登録代理店情報 i
カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更はこちら
#6241S300 μL50,000
ログインすると国内在庫状況がご確認いただけます。

Chk1抗体製品一覧

テストした細胞種
HeLa(ヒト)、COS(サル)
特異性
Chk1 タンパク質の発現を抑制します。
貯法
-20℃
社内データ

Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa cells transfected with non-targeted (-) or targeted (+) siRNA. Chk1 was detected using the Chk1 Antibody #2345, and p42 was detected using the p42 MAPK Antibody #9108. The Chk1 Antibody confirms silencing of Chk1 expression, and the p42 MAPK Antibody was used to control for loading and specificity of Chk1 siRNA.

Fluorescent Detection

Fluorescent Detection

Fluorescent detection of SignalSilence® Control siRNA (Fluorescein Conjugate) #6201 in living HeLa cells 24 hours post-transfection, demonstrating nearly 100% transfection efficiency.

バックグラウンド

Chk1 kinase acts downstream of ATM/ATR kinase to play an important role in DNA damage checkpoint control, embryonic development and tumor suppression (1). Activation of Chk1 involves phosphorylation of Ser317 and Ser345 and occurs in response to blocked DNA replication and certain forms of genotoxic stress (2). Phosphorylation at Ser 345 serves to localize Chk1 to the nucleus (3) following checkpoint acitvation while recently phosphorylation at Ser 317 along with site-specific phosphorylation of PTEN was shown to allow for reentry into the cell cycle following stalled DNA replication. (4). Chk1 exerts it checkpoint mechanism on the cell cycle in part by regulating the cdc25 family of phosphatases. Chk1 phosphorylation of cdc25A targets it for proteolysis and inhibits it's activity though 14-3-3 binding. (5). Activated Chk1 can inactivate cdc25C via phosphorylation at Ser216, blocking the activation of cdc2 and transition into mitosis (6). Also, centrosomal Chk1 has been shown to phosphorylate cdc25B inhibiting its activation of CDK1-cyclin B1 and thus mitotic spindle formation and chromatin condensation (7). Furthermore, Chk1 plays a role in spindle checkpoint function through regulation of Aurora B and BubR1 (8). Chk1 has emerged as a drug target for cancer therapy as its inhibition leads to cell death in many cancer cell lines (9).

Small Interfering RNA (siRNA) has been used to specifically silence chk1 in various human cancer cell lines (5).

  1. Liu, Q. et al. (2000) Genes Dev 14, 1448-59.
  2. Zhao, H. and Piwnica-Worms, H. (2001) Mol Cell Biol 21, 4129-39.
  3. Jiang, K. et al. (2003) J Biol Chem 278, 25207-17.
  4. Martin, S.A. and Ouchi, T. (2008) Mol Cancer Ther 7, 2509-16.
  5. Chen, M.S. et al. (2003) Mol Cell Biol 23, 7488-97.
  6. Zeng, Y. et al. (1998) Nature 395, 507-10.
  7. Löffler, H. et al. (2006) Cell Cycle 5, 2543-7.
  8. Zachos, G. et al. (2007) Dev Cell 12, 247-60.
  9. Garber, K. (2005) J Natl Cancer Inst 97, 1026-8.
  10. Chen, Z. et al. (2003) Mol. Cancer Ther. 2(6) , 543-548.
使用例
製品をご使用いただいて研究を発表されましたら、ぜひお知らせください
 
関連製品
2345   Chk1 Antibody
6201   SignalSilence Control siRNA (Fluorescein Conjugate)
6240   SignalSilence Chk1 siRNA Kit (Human Specific)
7003   20X LumiGLO Reagent and 20X Peroxide
7071   Phototope-HRP Western Blot Detection System (with Anti-rabbit IgG, HRP-linked Antibody)
7074   Anti-rabbit IgG, HRP-linked Antibody
7720   Prestained Protein Marker, Broad Range (Premixed Format)
7727   Biotinylated Protein Ladder Detection Pack

本製品は試験研究用です。

SignalSilence Chk1 siRNA I

Product Pathways

Tools

Applications